Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4.28M | $42.0M | 6.72% | +640.6K | 2026-06-30 |
| VIKING GLOBAL INVESTORS LP | 3.58M | $35.0M | 5.61% | -- | 2026-06-30 |
| Erste Asset Management GmbH | 2.54M | $25.0M | 3.98% | +589.2K | 2026-06-30 |
| BAILLIE GIFFORD & CO | 2.39M | $23.0M | 3.75% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.09M | $20.0M | 3.28% | +172.9K | 2026-06-30 |
| Anchorage Capital Group, L.L.C. | 1.75M | $17.0M | 2.74% | -- | 2026-06-30 |
| Legal & General Group Plc | 1.67M | $16.0M | 2.62% | +7.8K | 2026-06-30 |
| STATE STREET CORP | 1.47M | $14.0M | 2.31% | +125.7K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.22M | $12.0M | 1.92% | +212.7K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 937.8K | $9.0M | 1.47% | +372.2K | 2026-06-30 |
